Dbv technologies to participate in the h.c. wainwright 26th annual global investment conference

ChÂtillon, france, september 4, 2024 dbv technologies to participate in the h.c. wainwright 26 th annual global investment conference dbv technologies (euronext: dbv – isin: fr0010417345 – nasdaq stock market: dbvt), a clinical-stage biopharmaceutical company, today announced that daniel tassÉ, chief executive officer, will participate in a fireside chat at the h.c.
DBVT Ratings Summary
DBVT Quant Ranking